课题基金 / 基金详情

Mucosal innate immunity in HIV resistant women

Mucosal innate immunity in HIV resistant women
艾滋病毒耐药女性的粘膜先天免疫
批准号：
237486
负责人：
Roger Michel
金额：
$20.13万
依托单位：
Centre hospitalier de l'Universit de Montral (CHUM)
依托单位国家：
加拿大
项目类别：
Operating Grants
财政年份：
2011
资助国家：
加拿大
项目状态：
已结题
起止时间：
2011-09-01 至 2014-09-01
来源：
https://webapps.cihr-irsc.gc.ca/decisions/p/project_details.html?applId=237486&lang=en
关键词：
Cell Phenotype Analysis By Flow Cytometry Cytokine/Chemokine Measurements Female Commercial Sex Workers Genital Mucosal Immunity Hiv Susceptibility/Resistance Hiv/Aids Pathogenesis

项目摘要

项目成果

Roger Michel的其他基金

相关文献

中文摘要
翻译
大多数艾滋病毒感染是通过异性性行为获得的，感染艾滋病毒的妇女的比率每年都在急剧增加。在性传播期间首次接触艾滋病毒-1发生在生殖道，然而，人们对艾滋病毒-1知之甚少。
英文摘要
Most HIV infections are acquired through heterosexual intercourse, and each year the rate of HIV-infected women increases dramatically. Initial exposure to HIV-1 during sexual transmission occurs in the genital tract, however, little is known about HIV-1-
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Mucosal innate immunity in HIV resistant women
Identification of Blys/BAFF as a new therapeutic target for limiting immune activation and viral reservoirs during HIV/SIV infection
Modulation of BLyS levels to restore immune efficiency and reduce HIV targets.